Explore more publications!

Cincinnati Wellness Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.

Press releases published on September 29, 2025

Arcutis Biotherapeutics to Host Virtual Investor Day and Report Third Quarter 2025 Financial Results on October 28, 2025
Dr. Robert Corkern Launches Healthcare Innovation Grant for Undergraduate Students Nationwide
Dr. Omar Massoud Announces the Launch of the Dr. Omar Massoud Scholarship for Future Doctors
Glo & Spa-rkle Aesthetics and Medical Spa Launches Revolutionary Near-Painless and Precise PRP and PRF Hair Restoration Intradermal Injector Treatment
Compass Health CEO honored with Lifetime Achievement Award from Vistage, the world’s largest CEO coaching and advisory organization
Lighthouse Autism Center Announces Expansion in North Carolina with High Point Location
Silo Pharma Updates Strategic Agreement with Fireblocks to Secure Crypto Treasury Management
Peanut Allergy Clinical Trial Pipeline: Insights into a Growing Landscape with 12+ Companies Advancing Novel Treatments| DelveInsight
Tria Federal Unveils Tria Forge, a Serverless AI Platform That Empowers Organizations to Build Secure, Codeless AI Tools
As subsidy enhancements’ future remains uncertain, new Marketplace rule and recent legislation bring big shifts for 2026
Konsumenci w Warszawie wzywają przywódców UE do ochrony saszetek nikotynowych i wsparcia redukcji szkód**
Predictive Oncology Inc. Announces Private Placements of $344 Million to Initiate a Digital Asset Treasury Strategy Focused on Aethir (ATH) Tokens
Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary
Revolution Medicines Announces Key Leadership Additions, including Alan Sandler, M.D. as Chief Development Officer
Revagenix, Inc. Announces Changes to Its Board of Directors
Cue Biopharma Announces Strategic Transition in Leadership to Further Enable Next Stage of Growth with Disruptive Autoimmune Therapeutic Candidates
Outlook Therapeutics Provides Update on Type A Meeting with FDA
SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children
Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 in Duchenne Muscular Dystrophy
Sofwave to Participate in the Jefferies Virtual Private MedTech Summit

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions